Janus Henderson Group plc 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 12:00 pm Purchase | 2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 4,557,920 13.700% | 218,666 (+5.04%) | Filing |
| 2025-02-14 11:55 am Purchase | 2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 4,339,254 13.100% | 576,059 (+15.31%) | Filing |
| 2024-11-14 12:32 pm Purchase | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 3,763,195 11.400% | 369,908 (+10.90%) | Filing |
| 2024-08-05 12:54 pm Purchase | 2024-07-25 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 3,393,287 10.300% | 1,062,549 (+45.59%) | Filing |
| 2024-02-14 1:43 pm Purchase | 2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | JANUS HENDERSON GROUP PLC JHG | 2,330,738 8.700% | 2,330,738 (New Position) | Filing |